Greenwich LifeSciences, Inc.

NASDAQ:GLSI

Biotechnology

Healthcare
$19.79 -3.08%

-$0.74 today

Market cap
$290.48M
Beta
1.38
P/E (TTM)
-15.6
EPS (TTM)
-$1.49
52W Low $7.78High $34.10

Volume 0.23M

Average 0.14M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$19.45M

FY 2025 · Annual

Net Income

-$19.36M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue3.61K3.61K3.61K3.61K1.78K
Gross Profit(3.61K)(3.61K)(3.61K)(3.61K)(1.78K)
Gross Margin—————
Research & Development3.56M6.48M7.7M15.48M17.22M
Selling, General & Admin1.04M1.56M1.63M2.15M2.23M
Operating Expenses4.59M8.04M9.32M17.63M19.45M
Depreciation & Amortization3.61K3.61K3.61K3.61K1.78K
EBITDA(4.57M)(7.82M)(8.89M)(17.41M)(19.36M)
EBITDA Margin—————
Operating Income(4.6M)(8.04M)(9.33M)(17.64M)(19.45M)
Operating Margin—————
Interest Income27.37K215.02K436.06K223.01K89.7K
Interest Expense00000
Other Income / Expenses27.37K215.02K436.06K223.01K89.7K
Income Before Tax(4.57M)(7.83M)(8.89M)(17.41M)(19.36M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(4.57M)(7.83M)(8.89M)(17.41M)(19.36M)
Net Margin—————
EPS (Basic)(0.35)(0.61)(0.69)(1.21)(1.43)
EPS (Diluted)(0.35)(0.61)(0.69)(1.21)(1.43)
Weighted Avg Shares12.94M12.91M12.85M13.01M13.53M
Weighted Avg Shares (Diluted)12.94M12.91M12.85M13.01M13.53M

GLSI Earnings Waterfall · TTM

NASDAQ:GLSI · Revenue to Net Income

Key Ratios

EPS$-1.57
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-10.1
P/S Ratio0.0

Analysis

$0 of revenue converted into -$21.8M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.57, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
DEFA14ADEFA14A filingOct 26, 2026
DEF 14ADEF 14A filingOct 26, 2026
ARSARS filingOct 26, 2026
10-QQuarterly reportAug 11, 2026
4Statement of changes in beneficial ownershipJul 30, 2026

How much revenue does GLSI generate?

Greenwich LifeSciences, Inc. (GLSI) reported $0.00 of revenue in fiscal 2025.

Is GLSI profitable?

Greenwich LifeSciences, Inc. (GLSI) reported -$19.36M of net income.